Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Middleton, Wisconsin


Purpose:

A study of the safety and efficacy of duloxetine in elderly patients (greater than 65 years old) with major depressive disorder


Study summary:

Duloxetine 60 mg QD and placebo variable-duration, placebo lead-in period 9 weeks in the acute treatment phase


Criteria:

Inclusion Criteria: - You must be able to visit the doctor's office for clinic visits, tests, and procedures. - You must have been diagnosed with major depression, and have had at least one other episode in the past. Exclusion Criteria: - You have a current or previous major psychiatric disorder other than depression, such as bipolar disorder, schizophrenia, or other psychotic disorder. - You have taken a drug within the last 30 days that has not been approved for use by governmental authorities.


NCT ID:

NCT00062673


Primary Contact:

Study Director
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST)
Eli Lilly and Company


Backup Contact:

N/A


Location Contact:

Middleton, Wisconsin
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: December 11, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.